A Study of AK3280 in Chinese Healthy Volunteers
Clinical trial NCT04926116 · COMPLETED
Trial details
- NCT number
- NCT04926116
- Sponsor
- Shanghai Ark Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-09
- Primary completion
- 2021-09-28
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.